Dianthus Therapeutics | Capitale Sociale E Riserve

Prezzo Delle Azioni
50.75
Cambio Giornaliero
4.17 8.95%
Mensile
33.24%
Annuale
120.17%
Q1 Previsione
49.19




Capitale Sociale E Riserve Cambiamento Data
Alaunos Therapeutics USD 2.8M 858K 2025-09
Avita Medical AUD -12.89M 17.39M 2025-06
Celltrion KRW 16.7T 182.36B 2025-09
Cspc Pharmaceutical CNY 33.25B 984.93M 2025-06
Dianthus Therapeutics USD 546.45M 243.38M 2025-09
Divis Laboratories Ltd INR 154.13B 4.44B 2025-09
IQVIA Holdings USD 6.5B 343M 2025-12
Kangmei Pharma CNY 7.22B 504.3M 2025-09
Knight Therapeutics CAD 773.91M 11.11M 2024-09
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 55.1M 229K 2025-06
Moderna USD 9.33B 69M 2025-09
Neuren Pharmaceuticals AUD 323.27M 40.63M 2025-06
Organigram Holdings CAD 349.13M 36.37M 2025-09
Organon & Co USD 906M 173M 2025-09
Pharma Mar EUR 197.51M 4.02M 2025-09
Qiagen NV USD 3.65B 143.93M 2025-09
Revvity USD 7.38B 180.27M 2025-09
Sartorius EUR 2.67B 9.9M 2025-09
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Tectonic Therapeutic USD 267.53M 16.24M 2025-09
Tilray USD 1.51B 1.22B 2025-03
Viatris USD 15.22B 352.9M 2025-09
Xeris Pharmaceuticals USD -861K 18.44M 2025-09
Zz Pientze Pharmaceu CNY 14.47B 173.2M 2025-09


Dianthus Therapeutics Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.